PA
PPHMP

Perceptive Advisors’s Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible PPHMP Stock Holding History

Perceptive Advisors’s Portfolio PPHMP Stock Details PPHMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200,000
Closed -$4.34M – 184
2017
Q1 		$4.34M Hold
200,000
– – 0.25% 66
2016
Q4 		$3.98M Buy
+200,000
New +$3.98M 0.28% 63